Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis

This commentary highlights the findings by Tao et al. (Theranostics 2016; 6: 2068-2083) that targeting miR-433 may be a potential therapeutic strategy for myocardial fibrosis and subsequently discusses the obstacles and prospects associated with the application of therapeutic microRNAs in anti-fibro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhongxiu, Li, Yajiao, Dian, Ke, Rao, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505060/
https://www.ncbi.nlm.nih.gov/pubmed/28740551
http://dx.doi.org/10.7150/thno.19286
Descripción
Sumario:This commentary highlights the findings by Tao et al. (Theranostics 2016; 6: 2068-2083) that targeting miR-433 may be a potential therapeutic strategy for myocardial fibrosis and subsequently discusses the obstacles and prospects associated with the application of therapeutic microRNAs in anti-fibrosis treatment.

Ejemplares similares